| 000 | 01809 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515123052.0 | ||
| 264 | 0 | _c20081218 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/bjp.2008.231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYeung, Sym | |
| 245 | 0 | 0 |
_aBimodal effects of the Kv7 channel activator retigabine on vascular K+ currents. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cSep 2008 |
||
| 300 |
_a62-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminopyridines _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthracenes _xpharmacology |
| 650 | 0 | 4 |
_aCarbamates _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aKCNQ Potassium Channels _xagonists |
| 650 | 0 | 4 |
_aKCNQ1 Potassium Channel _xagonists |
| 650 | 0 | 4 | _aMembrane Potentials |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aMyocytes, Smooth Muscle _xdrug effects |
| 650 | 0 | 4 |
_aPhenylenediamines _xpharmacology |
| 650 | 0 | 4 |
_aPortal Vein _xdrug effects |
| 650 | 0 | 4 |
_aPotassium _xmetabolism |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aRecombinant Proteins _xagonists |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 650 | 0 | 4 | _aXenopus laevis |
| 700 | 1 | _aSchwake, M | |
| 700 | 1 | _aPucovský, V | |
| 700 | 1 | _aGreenwood, Ia | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 155 _gno. 1 _gp. 62-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjp.2008.231 _zAvailable from publisher's website |
| 999 |
_c18022668 _d18022668 |
||